Bioceres Crop Solutions (NASDAQ:BIOX) Issues Quarterly Earnings Results

Bioceres Crop Solutions (NASDAQ:BIOX) posted its quarterly earnings results on Monday. The company reported ($0.09) earnings per share for the quarter, missing the consensus estimate of $0.02 by ($0.11), Zacks reports. The company had revenue of $92.60 million during the quarter, compared to analysts’ expectations of $117.15 million. Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.53%. During the same quarter in the previous year, the company earned ($0.07) EPS.

Bioceres Crop Solutions Stock Performance

Shares of BIOX traded up $0.44 during trading hours on Wednesday, hitting $7.10. The stock had a trading volume of 362,489 shares, compared to its average volume of 87,752. Bioceres Crop Solutions has a fifty-two week low of $5.71 and a fifty-two week high of $14.05. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.86 and a current ratio of 1.24. The firm has a market capitalization of $446.24 million, a price-to-earnings ratio of 360.68 and a beta of 0.49. The firm has a 50-day moving average price of $7.73 and a 200 day moving average price of $9.85.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on BIOX shares. Canaccord Genuity Group lowered their price target on Bioceres Crop Solutions from $10.00 to $9.50 and set a “buy” rating on the stock in a report on Wednesday. Oppenheimer cut their target price on Bioceres Crop Solutions from $16.00 to $13.00 and set an “outperform” rating for the company in a research report on Monday, October 21st. Roth Mkm dropped their price target on Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating for the company in a research note on Wednesday, September 11th. Canaccord Genuity Group upgraded shares of Bioceres Crop Solutions to a “strong-buy” rating in a research report on Friday, July 19th. Finally, Lake Street Capital dropped their price target on shares of Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating for the company in a research note on Wednesday, September 11th. Four equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of $12.13.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.